In a study investigating the CXCL12/CXCR4/ACKR3 axis in rhabdomyosarcomas, ACKR3 promoter activity was shown to depend on an NF-κB binding site [55]. This evidence concerns the gene NFKB1 and rhabdomyosarcoma.